These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6176801)

  • 1. Pharmacokinetic and pharmacodynamic properties of alinidine in man.
    Wiegand UW; Kasper W; Meinertz T; Stützle U; Jähnchen E
    J Cardiovasc Pharmacol; 1982; 4(1):59-62. PubMed ID: 6176801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.
    Harron DW; Arndts D; Finch M; Shanks RG
    Br J Clin Pharmacol; 1983 Oct; 16(4):451-5. PubMed ID: 6626441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man.
    Harron DW; Jady K; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):213-20. PubMed ID: 6175803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradycardic effect of alinidine on in situ and on isolated, blood-perfused heart preparations of dogs.
    Ogiwara Y; Furukawa Y; Saegusa K; Takeda M; Chiba S
    Arch Int Pharmacodyn Ther; 1988; 291():41-54. PubMed ID: 2835022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
    Harron DW; Deering AH; Scott M; McMahon M; Shanks RG
    Br J Clin Pharmacol; 1989 Jan; 27(1):23-9. PubMed ID: 2495813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proof of the linearity of the pharmacokinetics of alinidine in man.
    Arndts D; Warnkross H; Rominger KL; Justus H
    Eur J Clin Pharmacol; 1981; 21(3):201-7. PubMed ID: 7318879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing.
    Verdouw PD; Saxena PR; Schamhardt HC; van der Hoek TM; Rutteman AM
    Eur J Pharmacol; 1980 Jun; 64(4):209-20. PubMed ID: 7389819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alinidine pharmacokinetics following acute and chronic dosing.
    Harron DW; Arndts D; Shanks RG
    Br J Clin Pharmacol; 1982 Jun; 13(6):821-7. PubMed ID: 7093113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.
    Arndts D; Leb G; Förster HJ
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):225-36. PubMed ID: 7308242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of cardiovascular effects of clonidine and alinidine in cross-perfused dog atrial preparations.
    Chiba S; Ogiwara Y; Furukawa Y; Akahane K
    Jpn Heart J; 1989 Nov; 30(6):895-902. PubMed ID: 2632839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of N-allyl clonidine (ST 567, alinidine): a substance with specific bradycardiac action during neuroleptanesthesia in humans.
    Fitzal S; Zimpfer M
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):404-7. PubMed ID: 7141760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.
    Boucher M; Chapuy E; Lefebvre MA; Mignot A; Duchêne-Marullaz P
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):630-7. PubMed ID: 2570365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of alinidine in symptom-free asthmatics.
    Lichey J; Hoffmann M; Huckauf H; Kammradt G; Friedrich T
    Eur J Clin Pharmacol; 1986; 31(4):427-30. PubMed ID: 3816922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
    Boucher M; Chassaing C; Chapuy E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M; Chassaing C; Chapuy E
    Eur J Pharmacol; 1996 Jun; 306(1-3):93-8. PubMed ID: 8813620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of alinidine on heart rate and blood pressure in healthy subjects and patients with hyperkinetic heart syndrome.
    Stanek B; Reiterer W; Placheta P; Raberger G
    Eur J Clin Pharmacol; 1983; 24(1):31-4. PubMed ID: 6832198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alinidine (ST 567) on baroreceptor-heart rate reflexes and its interactions with clonidine on the baroreflex and on the sympathetic terminals of the isolated atrium.
    Heinzow BG; Angus JA; Korner PI
    Eur J Pharmacol; 1982 Oct; 84(3-4):177-87. PubMed ID: 7173318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alinidine on metabolic response to high-demand myocardial ischemia.
    Hanet C; Pouleur H; Hue L; Caucheteux D; Gurné O; Maldague P; Rousseau MF
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):405-11. PubMed ID: 2471886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in systemic haemodynamics, regional myocardial function and perfusion induced by alinidine in pigs with and without narrowed coronary arteries.
    Verdouw PD; Duncker DJ; Heere TJ; Saxena PR
    Eur Heart J; 1987 Dec; 8 Suppl L():43-52. PubMed ID: 3451882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.